Loading data
VEEENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.82 m USD | 14.39 m USD | 33.43 m USD | 31.99 m USD | 15.77 m USD |
| Cost of revenue | 13.56 m USD | 15.14 m USD | 30.16 m USD | 21.33 m USD | 9.5 m USD |
| Gross profit | 1.26 m USD | -751.43 k USD | 3.27 m USD | 10.66 m USD | 6.28 m USD |
| Research and development expense | — | 586.38 k USD | 1.44 m USD | 941.53 k USD | 211.11 k USD |
| Selling, general and administrative expense | 2.5 m USD | 3.1 m USD | 3.73 m USD | 2.76 m USD | 1.73 m USD |
| Operating profit | -8.78 m USD | -14.55 m USD | -11.99 m USD | -6.02 m USD | -1.63 m USD |
| Net income (reported basis) | -8.61 m USD | -11.05 m USD | -7.19 m USD | -5.14 m USD | -1.01 m USD |
| Net income attributable to common shareholders | — | — | — | -5.14 m USD | -1.01 m USD |
| Basic earnings per share | -4.37 USD/share | -11.01 USD/share | -0.76 USD/share | -0.67 USD/share | -0.19 USD/share |
| Diluted earnings per share | -4.37 USD/share | -11.01 USD/share | -0.76 USD/share | -0.67 USD/share | -0.19 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.